X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1524) 1524
Book Review (149) 149
Publication (90) 90
Book Chapter (14) 14
Book / eBook (7) 7
Conference Proceeding (6) 6
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1367) 1367
actinobacteria (774) 774
bacteria (753) 753
microbiology (654) 654
humans (511) 511
research article (437) 437
biology and life sciences (396) 396
organisms (393) 393
medicine (365) 365
medicine and health sciences (359) 359
multidisciplinary sciences (344) 344
tuberculosis (343) 343
research (330) 330
analysis (329) 329
science (324) 324
actinobacteria - metabolism (318) 318
mycobacterium tuberculosis (312) 312
animals (311) 311
infectious diseases (311) 311
biotechnology & applied microbiology (294) 294
actinobacteria - genetics (290) 290
antibiotics (275) 275
phylogeny (249) 249
bacterial diseases (248) 248
tropical diseases (244) 244
female (239) 239
actinobacteria - isolation & purification (238) 238
immunology (228) 228
infections (212) 212
anti-bacterial agents - pharmacology (207) 207
male (206) 206
studies (205) 205
actinobacteria - chemistry (202) 202
microbial sensitivity tests (202) 202
life sciences (193) 193
actinobacteria - drug effects (190) 190
research and analysis methods (190) 190
biotechnology (182) 182
rna, ribosomal, 16s - genetics (181) 181
physiological aspects (180) 180
actinomycetes (178) 178
biosynthesis (174) 174
metabolites (173) 173
diversity (169) 169
biochemistry (168) 168
proteins (168) 168
soil microbiology (164) 164
streptomyces (164) 164
drug resistance (161) 161
physiology (159) 159
actinobacteria - classification (156) 156
adult (156) 156
microorganisms (156) 156
pathogens (150) 150
cell biology (149) 149
enzymes (142) 142
identification (138) 138
health aspects (137) 137
genetics (131) 131
genetic aspects (129) 129
biology (127) 127
laboratories (127) 127
genes (126) 126
middle aged (123) 123
sequence analysis, dna (123) 123
patients (122) 122
molecular sequence data (120) 120
medical microbiology (119) 119
mice (119) 119
pathology and laboratory medicine (119) 119
diagnostic medicine (118) 118
pharmacology & pharmacy (117) 117
natural-products (116) 116
diagnosis (115) 115
pharmacology (115) 115
molecular biology (113) 113
dna, bacterial - genetics (111) 111
genomics (108) 108
risk factors (105) 105
bacteria - drug effects (104) 104
rna (102) 102
biochemistry & molecular biology (101) 101
chemistry (101) 101
gene expression (101) 101
care and treatment (100) 100
public health (99) 99
drugs (96) 96
animal cells (94) 94
cellular types (94) 94
gene (94) 94
immune cells (93) 93
anti-bacterial agents - chemistry (92) 92
bacterial proteins - genetics (92) 92
chemistry, medicinal (92) 92
physical sciences (92) 92
fermentation (91) 91
metabolism (90) 90
natural products (90) 90
actinobacteria - physiology (89) 89
bacterial proteins - metabolism (89) 89
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1515) 1515
Chinese (8) 8
Russian (8) 8
French (2) 2
Spanish (2) 2
Bulgarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2012, Volume 56, Issue 11, pp. 5811 - 5820
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 09/2015, Volume 42, Issue 5, pp. 515 - 528
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 4, pp. 1314 - 1322.e5
Background & Aims Proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used classes of drugs, with the... 
Gastroenterology and Hepatology | Ulcer | Microflora | Bleeding | Acid Secretion | ULCERS | NONSTEROIDAL ANTIINFLAMMATORY DRUG | PERMEABILITY | RATS | INDOMETHACIN | LEUKOCYTE ADHERENCE | INDUCED GASTRIC DAMAGE | PATHOGENESIS | NITRIC-OXIDE | BACTERIAL OVERGROWTH | GASTROENTEROLOGY & HEPATOLOGY | Jejunum - pathology | Rats, Wistar | Colon - drug effects | Hematocrit | Peptic Ulcer - prevention & control | Male | Omeprazole - toxicity | Bifidobacterium - isolation & purification | Bifidobacterium - growth & development | Actinobacteria - drug effects | Jejunum - drug effects | Drug Interactions | Peptic Ulcer - microbiology | Time Factors | Actinobacteria - genetics | Actinobacteria - isolation & purification | Disease Models, Animal | Bifidobacterium - genetics | Jejunum - microbiology | Rats | Celecoxib | Probiotics - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Proton Pump Inhibitors - toxicity | Anti-Inflammatory Agents, Non-Steroidal - toxicity | Peptic Ulcer - pathology | Denaturing Gradient Gel Electrophoresis | 2-Pyridinylmethylsulfinylbenzimidazoles - toxicity | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Bifidobacterium - drug effects | Animals | Gastrointestinal Hemorrhage - microbiology | Actinobacteria - growth & development | Pyrazoles - toxicity | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Naproxen - toxicity | Sulfonamides - toxicity | Colon - microbiology | Peptic Ulcer - chemically induced | Gastrointestinal Hemorrhage - pathology | Lansoprazole | Proton pump inhibitors | Messenger RNA | Nonsteroidal anti-inflammatory drugs | Index Medicus | Abridged Index Medicus
Journal Article
Applied and Environmental Microbiology, ISSN 0099-2240, 2016, Volume 82, Issue 3, pp. 778 - 787
Bromochloromethane (BCM), an inhibitor of methanogenesis, has been used in animal production. However, little is known about its impact on the intestinal... 
AMINO-ACID-METABOLISM | GEL-ELECTROPHORESIS ANALYSIS | METHANOGENIC BACTERIA | DIETARY-PROTEIN | RUMEN FERMENTATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | BIOGENIC-AMINES | MICROBIOLOGY | SP-NOV | HYDROGEN-SULFIDE | GUT MICROBIOTA | SULFATE-REDUCING BACTERIA | Intestines - drug effects | Carbohydrate Metabolism - drug effects | Proteobacteria - metabolism | Rats, Wistar | Gastrointestinal Microbiome - physiology | Intestines - metabolism | Cecum - microbiology | Proteobacteria - genetics | Actinobacteria - drug effects | Euryarchaeota - genetics | Cecum - metabolism | Actinobacteria - genetics | Actinobacteria - metabolism | Acidobacteria - genetics | Hydrocarbons, Halogenated - pharmacology | Euryarchaeota - classification | RNA, Ribosomal, 16S - metabolism | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Acidobacteria - metabolism | Fermentation | Gastrointestinal Microbiome - genetics | Euryarchaeota - drug effects | Proteobacteria - drug effects | Sequence Analysis, DNA | Cecum - drug effects | Metabolome - genetics | Animals | Gastrointestinal Microbiome - drug effects | Intestines - microbiology | Euryarchaeota - metabolism | Metabolome - drug effects | Lipid Metabolism - drug effects | Acidobacteria - drug effects | Hydrocarbons, Halogenated - administration & dosage | Microbiota (Symbiotic organisms) | Gastrointestinal system | Analysis | Rattus | Rats | Genetic aspects | Research | Methane | Microorganisms | Metabolism | Digestive system | Rodents | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2017, Volume 61, Issue 12
Pexiganan, a cationic peptide, exhibited a broad range of anti-anaerobic antimicrobial activity. The MIC90s of studied isolates were as follows: Bacteroides... 
Pexiganan | Finegoldia magna | Anaerobes | Topical antimicrobials | Bacteroides fragilis | Propionibacterium acnes | Clostridia | Wound infections | clostridia | BACTERIOLOGY | pexiganan | wound infections | DIABETIC FOOT INFECTIONS | topical antimicrobials | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | anaerobes | Peptostreptococcus - drug effects | Skin - microbiology | Porphyromonas - drug effects | Propionibacterium acnes - growth & development | United States | Humans | Bacteroides fragilis - drug effects | Actinobacteria - drug effects | Clostridium perfringens - isolation & purification | Fusobacterium - drug effects | Microbial Sensitivity Tests | Skin Diseases, Infectious - microbiology | Sweden | Prevotella - growth & development | Bacteroides fragilis - growth & development | Actinobacteria - isolation & purification | Porphyromonas - isolation & purification | Fusobacterium - growth & development | Skin - pathology | Firmicutes - growth & development | Amino Acid Sequence | Antimicrobial Cationic Peptides - chemical synthesis | Anaerobiosis - physiology | Firmicutes - isolation & purification | Skin Diseases, Infectious - pathology | Antimicrobial Cationic Peptides - pharmacology | Peptostreptococcus - isolation & purification | Prevotella - drug effects | Anti-Bacterial Agents - chemical synthesis | Bacteroides fragilis - isolation & purification | Canada | Clostridium perfringens - drug effects | Peptostreptococcus - growth & development | Clostridium perfringens - growth & development | Actinobacteria - growth & development | Propionibacterium acnes - isolation & purification | Anti-Bacterial Agents - pharmacology | Porphyromonas - growth & development | Firmicutes - drug effects | Prevotella - isolation & purification | Propionibacterium acnes - drug effects | Fusobacterium - isolation & purification | Index Medicus
Journal Article
Journal Article
PLOS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, pp. e0159539 - e0159539
Psoriasis is a chronic inflammatory skin disease in which Th17 cells play a crucial role. Since indigenous gut microbiota influences the development and... 
MUCOSAL BARRIER | DIET | ALTERED GUT MICROBIOTA | MULTIDISCIPLINARY SCIENCES | DISEASE | PROBIOTICS | BACTERIAL OVERGROWTH | ROSACEA | GERM-FREE | T-CELLS | MANIFESTATIONS | Skin - microbiology | Species Specificity | Humans | Interleukin-17 - immunology | Receptors, Antigen, T-Cell, gamma-delta - genetics | Gastrointestinal Microbiome - physiology | Actinobacteria - drug effects | Clostridiales - drug effects | Th17 Cells - drug effects | Lactobacillales - physiology | Psoriasis - pathology | Female | Actinobacteria - physiology | Aminoquinolines - pharmacology | Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics | Skin - pathology | Disease Models, Animal | Skin - immunology | Psoriasis - immunology | Nuclear Receptor Subfamily 1, Group F, Member 3 - immunology | Gene Expression | Clostridiales - physiology | Mice, Inbred C57BL | Interleukin-17 - genetics | Psoriasis - microbiology | Receptors, Antigen, T-Cell, gamma-delta - immunology | Animals | Gastrointestinal Microbiome - drug effects | Lactobacillales - drug effects | Lymphocyte Activation - drug effects | Psoriasis - chemically induced | Germ-Free Life | Th17 Cells - immunology | Anti-Bacterial Agents - pharmacology | Mice | Mice, Inbred BALB C | Skin - drug effects | Th17 Cells - microbiology | Animal experimentation | Antibiotics | Microbiota (Symbiotic organisms) | Psoriasis | Dosage and administration | Research | Drug therapy | Health aspects | Risk factors | Drinking water | Animal models | Imiquimod | Helper cells | Lymphocytes T | Arthritis | Skin resistance | Experiments | Inflammatory diseases | Microbiota | Lymphocytes | Intestine | Skin diseases | Bacteria | Intestinal microflora | Lesions | Digestive tract | Systems development | Rosacea | Immune system | Medical research | Gnotobiotics | Dermatology | Digestive system | Acne | Inflammation | Inflammatory bowel disease | Immune systems | Probiotics | Index Medicus
Journal Article